Numerous studies have reported elevated resistin levels in both premenopausal and post-menopausal breast cancer patients, suggesting its potential as a diagnostic marker for breast cancer.132, 133, 134 Notably, breast cancer patients with a BMI exceeding 25kg/m2 displayed higher serum resistin levels than controls with a BMI below this threshold.134. This evidence concerns the gene RETN and breast carcinoma.